重度主动脉瓣狭窄晚期心脏损伤对TAVI术后短期与中期死亡率和再住院的影响:系统综述与荟萃分析
结果显示12个月全因死亡风险随心脏损伤分期加重而升高,4期风险最高,心血管死亡和再住院风险亦增加。将心脏损伤分期纳入术前评估有助于风险分层。
要点
- 12个月全因死亡HR随心脏损伤分期加重而递增,4期达2.77。
- 4期患者心血管死亡风险最高,HR 3.13,RR 2.63。
- 3期再住院风险升高,RR 1.33。
核心结论
- 瓣外心脏损伤尤其是右心室功能障碍(4期)与TAVI术后短期和中期死亡率及再住院风险增加强烈相关。
- 临界期患者风险也已升高,提示AS相关心脏损伤具有连续性。
研究设计与样本
- 采用随机效应荟萃分析,按Généreux分期、瓣膜类型和诊断方式做亚组分析,用JBI队列研究清单评估偏倚风险。
主要发现
- 12个月全因死亡HR:临界期1.61(1.22-2.12),3期2.06(1.63-2.60),4期2.77(2.11-3.64)。
- 4期心血管死亡HR 3.13(1.20-8.17),RR 2.63(1.54-4.47)。
- 3期再住院RR 1.33(1.12-1.58)。
- 荟萃回归显示年龄、性别和合并症贡献了研究间异质性,尤其在3期分析中。
临床怎么用
- 将心脏损伤分期纳入TAVI术前评估以增强风险分层。
- 对临界期及以上患者应加强围术期管理和随访。
局限性
- 再住院数据有限。
- 研究间存在异质性,部分由年龄、性别和合并症解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe aortic stenosis (AS) is commonly associated with advanced cardiac damage, including right ventricular dysfunction (RVD), pulmonary hypertension (PH) and tricuspid regurgitation (TR), which may worsen prognosis after transcatheter aortic valve implantation (TAVI). This systematic review and meta-analysis aimed to assess the effect of these conditions on short-term and mid-term mortality and rehospitalisation following TAVI. METHODS: We conducted a systematic search of PubMed, Scopus and Web of Science for studies published up to June 2025. Eligible studies included adults with AS undergoing TAVI and reported outcomes at 1 month, 6 months or 12 months stratified by the presence of RVD, PH or TR. Studies had to report either HRs, risk ratios (RRs) or sufficient raw event data for mortality or rehospitalisation. Data were synthesised using a random-effects meta-analysis. Subgroup analyses were conducted by cardiac damage severity according to the Généreux staging system and stratified by valve type and diagnostic modality. Risk of bias in included studies was assessed using the Joanna Briggs Institute's checklist for cohort studies. Meta-regression was performed to explore sources of between-study heterogeneity. RESULTS: A total of 34 studies including 26 076 patients met inclusion criteria. Twelve-month HRs for all-cause mortality increased with advancing cardiac damage: borderline stage HR 1.61 (1.22-2.12), stage 3 HR 2.06 (1.63-2.60) and stage 4 HR 2.77 (2.11-3.64). RRs followed a similar trend. Cardiovascular mortality was highest in stage 4 (HR 3.13 (1.20-8.17); RR 2.63 (1.54-4.47)). Rehospitalisation data were limited but suggested elevated risk in stage 3 (RR 1.33 (1.12-1.58)). Meta-regression indicated that age, sex and comorbidities contributed to between-study heterogeneity, particularly in stage 3 analyses. CONCLUSION: Extravalvular cardiac damage, especially RVD (stage 4), is strongly associated with increased short-term and mid-term mortality and rehospitalisation after TAVI. Even borderline-stage patients face elevated risk, underscoring the continuous nature of AS-related cardiac injury. Incorporating cardiac damage staging into preprocedural assessment can enhance risk stratification and guide management to improve patient outcomes. PROSPERO REGISTRATION NUMBER: CRD420250638838.
引用
- Baay M, Hosseini Z, Zadgari E, et al. Impact of advanced cardiac damage in severe aortic stenosis on short-term and mid-term mortality and rehospitalisation after transcatheter aortic valve implantation: a systematic review and meta-analysis. Heart. 2026. PMID: 41791868. doi:10.1136/heartjnl-2025-326941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。